Sort by
Keyphrases
Acinetobacter
9%
Adjusted Odds Ratio
54%
Antacids
9%
Confidence Interval
63%
Failure Index
9%
High Pathogenicity
36%
High Risk
9%
Histamine-2 Receptor Antagonists (H2RA)
9%
Hospital Mortality
45%
Hospitalization
9%
Independent Risk Factors
18%
Intubation
9%
Late-onset
100%
Lifestyle Measures
9%
Mechanical Ventilation
9%
Medical Surveillance
9%
Microorganisms
9%
Mortality Rate
9%
Non-surgical
9%
Nosocomial Pneumonia
9%
Organ System Failure
9%
Patient Data
9%
Patient Mortality
100%
Patient Outcomes
9%
Premorbid
9%
Primary Outcome Measure
9%
Prolonged Mechanical Ventilation
9%
Prospective Cohort Study
9%
Pseudomonas Aeruginosa (P. aeruginosa)
9%
Relative Risk
9%
Stepwise Logistic Regression Analysis
9%
Teaching Hospital
9%
University-affiliated
9%
Ventilator-associated Pneumonia
100%
Xanthomonas Maltophilia
9%
Pharmacology, Toxicology and Pharmaceutical Science
Acinetobacter
9%
Antacid Agent
9%
Histamine
9%
Hospital Mortality
45%
Infectious Agent
36%
Intubation
9%
Microorganism
9%
Mortality Rate
9%
Prospective Cohort Study
9%
Pseudomonas aeruginosa
9%
Receptor Antagonist
9%
Stenotrophomonas maltophilia
9%
Ventilator Associated Pneumonia
100%